Effect of Testofen on Erectile Function in an Adult Male Population
ConditionErectile Dysfunction
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexMale
Age40-75
SponsorRDC Clinical Pty Ltd
About this trial
This is a double blind, randomised, placebo-controlled clinical study with a 12-week participation and 3 groups (2 active groups and 1 placebo group) designed to monitor erectile function symptom severity and the effect Testofen may have on improving erectile function, sexual function, and quality of life.
Eligibility criteria
Qualifiers
Healthy male adults aged 40-75 years
Currently in a sexual relationship
Males with reduced erectile function (Score of <25 on IIEF)
BMI ≤ 35
Disqualifiers
History of prostate surgery and/or trauma
Receiving/prescribed treatment for erectile dysfunction, including oral medications, vacuum devices, constrictive devices, injections, or urethral suppositories
Receiving/prescribed treatment to increase/decrease testosterone levels e.g. androgens/anti androgens
Receiving/prescribed treatment to increase/decrease nitrate or nitric oxide levels
Trial design
Treatments tested in this trial
- Testofen 300mg
- Testofen 600mg
- Placebo comparator
Treatment groups
120 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov